American Type Culture Collection established the programme to assure consumers that products carrying this emblem meet ATCC's standards for quality and safety
ATCC (American Type Culture Collection), described as the world's largest nonprofit biological resource centre, unveiled its new ATCC Licensed Derivative programme and signed the first licence agreement under the programme with MicroBioLogics.
ATCC established the programme to assure consumers that products carrying this emblem meet ATCC's standards for quality and safety.
Biological resource centres collect, authenticate, preserve, and distribute biological materials for life science research.
These knowledge centres advance science by providing access and equitable distribution of biological materials such as cell lines, microorganisms, and reagents.
By joining the ATCC Licensed Derivative programme, companies agree to maintain the integrity of the ATCC ingredient contained in their product and allow ATCC to verify the quality of that ATCC ingredient before it reaches end-users.
In return, the ATCC Licensed Derivative emblem assures customers of the authenticity and quality of the ATCC ingredient contained in that product.
"Our industry is being reformed by global awareness; materials must be appropriately developed, handled, stored, used, shipped and disposed of in order to try to preserve the highest possible standards for health, safety and the environment," explained Robert Coborn, president and CEO, MicroBioLogics, a supplier of quality control microorganisms to clinical, pharmaceutical, cosmetic, food quality and environmental laboratories.
"This licence agreement offers MicroBioLogics and its distribution network verification of the ATCC materials used in MicroBioLogics products".
According to Raymond Cypess, ATCC pesident and CEO, the ATCC Licensed Derivative programme was created to protect the public, as well as private industry, government and academic organisations around the world that use ATCC-derived materials in their products and services.
"As a public science company, we take very seriously our responsibility in ensuring the safety and quality of the materials provided by ATCC," Cypess explained.
"Industrial scientists need to know with certainty that the materials at the foundation of their discoveries are authentic.
"By purchasing materials that carry the new ATCC Licensed Derivative emblem, customers can trust that the characteristics of the ATCC-derived products have been maintained and verified until they reach the end-users.
"We are very pleased that MicroBioLogics has become the first supplier to enter into a licence agreement with ATCC," said Cypess.
"This decision demonstrates MicroBioLogics's commitment to quality control microbiology".
"We are proud that MicroBioLogics is the first supplier to adopt the ATCC Licensed Derivative programme," Coborn said.
"It is an honour to have achieved the many levels of assurance and compliance required to gain the approval of ATCC as a licensed product manufacturer."
